MN

Molecular Neurodegeneration

Molecular Neurodegeneration is an open access neuroscience journal focused on neurodegeneration research at the molecular and cellular levels. As the official journal of the BrightFocus Foundation, it highlights advances in the molecular and cellular mechanisms underlying the pathogenesis of neurodegenerative disorders associated with aging.

Looking to publish in Molecular Neurodegeneration? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Neurosciences
Impact Factor 17.5
Quartile Q1
Open Access Type Open
eISSN 1750-1326
Invitation Only No
Cost Range £2590.00 GBP / $3190.00 USD / €2990.00 EUR; Perspective: £1215.00 GBP / $1720.00 USD / €1495.00 EUR

Submission Instructions

Molecular Neurodegeneration accepts the following article types. Click on an article type to view submission instructions.

Research

Cover Letter A cover letter is required. The cover letter must explain any issues relating to journal policies, declare any potential competing interests, confirm all authors approved the submission, confirm the manuscript has not been published or submitted elsewhere, and name the special issue if applicable.
Abstract An abstract is required. Abstract must not exceed 350 words. Abstract must be structured. Abstract must include the headings Background, Methods, Results, Conclusions, and Trial registration.
Manuscript Manuscript must include the sections Background, Methods, Results, Discussion, Conclusions, and a Declarations section. Manuscript must include three to ten keywords, a Declarations section with the specified subheadings using 'Not applicable' when a subheading is irrelevant, a list of abbreviations if abbreviations are used, and documentation of any Large Language Model use in the Methods section or suitable alternative part.
References References must use Vancouver style. Only published or publicly available articles, clinical trial registration records, abstracts, and preprints may be cited, unpublished abstracts/data/personal communications must not appear in the reference list, journal abbreviations must follow Index Medicus/MEDLINE, and URLs must be numbered and included in the reference list in full with site title and access date.
Figures & Tables Figure titles and legends must be provided in the main manuscript rather than in the graphic file, tables shorter than one page may be placed within the manuscript, and tables longer than one page may be placed at the end of the document with their placement indicated in the text. Multi-panel figures must be uploaded as single composite files, figures must be uploaded separately in citation order, and tables must not be embedded as figures or spreadsheet files.
Reformat to Molecular Neurodegeneration using Livewrite Premium

Review

Cover Letter A cover letter is required. The cover letter must explain any issues relating to journal policies, declare any potential competing interests, confirm that all authors approved the manuscript for submission, confirm that the manuscript has not been published or submitted elsewhere, and name the special issue if applicable.
Abstract An abstract is required. Abstract must not exceed 350 words. Abstract must be structured. Abstract must include Background, Main body of the abstract, and short Conclusion.
Manuscript Manuscript must include Background, Main text, Conclusions, Declarations, and an Availability of data and materials statement. Manuscript must include three to ten keywords, a list of abbreviations if abbreviations are used, and a Declarations section with the subheadings Ethics approval and consent to participate, Consent for publication, Availability of data and materials, Competing interests, Funding, Authors' contributions, and Acknowledgements, using 'Not applicable' for any irrelevant section.
References References must follow Vancouver style. Only published or in-press articles, clinical trial registration records, abstracts, and publicly available preprints may be cited, unpublished abstracts, unpublished data, and personal communications must not appear in the reference list, journal abbreviations must follow Index Medicus/MEDLINE, and web links and URLs must be numbered and included in the reference list with the site title, full URL, and access date.
Figures & Tables Figure titles and legends must be provided in the main manuscript rather than in the graphic file, tables shorter than one page may be placed within the manuscript, and tables longer than one page may be placed at the end of the document with in-text placement indicated. Figures must be numbered and uploaded in the order first cited, multi-panel figures must be submitted as a single composite file, and tables must be numbered and cited sequentially and created using the word processor's table function rather than embedded as figures or spreadsheet files.
Reformat to Molecular Neurodegeneration using Livewrite Premium

Letter To The Editor

Cover Letter Cover letter is required. Cover letter must explain any issues relating to journal policies, declare any potential competing interests, confirm that all authors have approved the manuscript for submission, confirm that the manuscript content has not been published or submitted elsewhere, and name the special issue if applicable.
Abstract Abstract is optional. If included, the abstract must be limited to one sentence. Abstract structure is not specified.
Manuscript Body text must be no more than 1000 words, excluding figure legends and references. Manuscript must start with "To the Editor" and the main text must not be divided into sections. Manuscript must include a Declarations section containing Ethics approval and consent to participate, Consent for publication, Availability of data and materials, Competing interests, Funding, Authors' contributions, Acknowledgements, and optional Authors' information, with "Not applicable" used for any non-relevant section.
References Manuscript must include no more than 10 references. References must use Vancouver style. Web links and URLs must be assigned a reference number and included in the reference list in full with the site title, URL, and access date.
Figures & Tables Manuscript may include a maximum of 1 figure or table at submission. Tables shorter than one page may be placed within the manuscript, while larger tables may be placed at the end of the document and must be cited in the text. Figure titles and legends must be provided in the main manuscript rather than in the graphic file.
Reformat to Molecular Neurodegeneration using Livewrite Premium

Recent Publications

LRRK2 and GBA1 in Lewy body diseases: neuropathological subtypes at opposite ends of a spectrum?

Vedika Jha, Lorraine V. Kalia

10.1186/s13024-026-00939-z
View Publication

Plasma proteomic signatures of preclinical Alzheimer’s disease in clinically unimpaired older adults

Alexandra N. Trelle, Karly A. Cody, Tran T. Nguyen, Joseph R. Winer, Skylar Weiss, Isha Sai, Tyler Ward, Gloria Cheng, Divya Channappa, Justin Mendiola, Amal Al-Rajhi, Keerthana Raghuraman, Sharon J. Sha, Edward N. Wilson, Tony Wyss-Coray, Holden T. Maecker, Anthony D. Wagner, Elizabeth C. Mormino

10.1186/s13024-026-00941-5
View Publication

Obesity-driven phosphatidylethanolamine dysregulation impairs neuroimmune crosstalk and accelerates Alzheimer’s pathogenesis

Li Yang, Jianting Sheng, Shaohua Qi, Zheng Yin, Michael Chan, Yuliang Cao, Hong Zhao, Zhihao Wan, Bill Chan, Ju Young Ahn, Xiaohui Yu, Matthew Vasquez, Shan Xu, Xianlin Han, Weiming Xia, Willa A. Hsueh, Stephen T. C. Wong

10.1186/s13024-026-00943-3
View Publication

Regional diffusion imaging measures to disentangle SVD-related hypertensive arteriopathy versus cerebral amyloid angiopathy

Sheelakumari Raghavan, Scott A. Przybelski, Robel K. Gebre, Audrey Low, Mingzhao Hu, Robert. I. Reid, B. Gwen Windham, Heather J. Wiste, Angela J. Fought, Michael G. Kamykowski, Aivi T. Nguyen, Melissa E. Murray, Val J. Lowe, Clifford R. Jr Jack, Ronald C. Petersen, Jonathan Graff-Radford, Prashanthi Vemuri

10.1186/s13024-026-00942-4
View Publication

PLCG2 signaling and genetic resilience in Alzheimer’s disease

Andy P. Tsai, Amara K. Martin, Andrew Mi, Ava E. Yeh, Eduardo Ramirez Lopez, Tony Wyss-Coray

10.1186/s13024-026-00935-3
View Publication

Frequently asked questions

How long does it take to publish?

Submission to first decision (median): 20 days

Reformat to Molecular Neurodegeneration using Livewrite Premium

Is a cover letter required?

A cover letter is required. It should explain why the manuscript should be published in Molecular Neurodegeneration, address any issues relating to journal policies, declare any potential competing interests, confirm that all authors approved the submission, confirm that the content has not been published or submitted elsewhere, and identify the special issue if applicable. Authors may also suggest preferred and non-preferred peer reviewers in the cover letter.

Reformat to Molecular Neurodegeneration using Livewrite Premium

What are the publication costs?

An article processing charge applies for each accepted article. The current APC is £2590.00 GBP / $3190.00 USD / €2990.00 EUR. The current APC for a Perspective is £1215.00 GBP / $1720.00 USD / €1495.00 EUR. VAT or local taxes may apply.

Reformat to Molecular Neurodegeneration using Livewrite Premium

Research Topics

Alzheimer's disease research and treatments Neuroinflammation and Neurodegeneration Mechanisms Parkinson's Disease Mechanisms and Treatments Amyotrophic Lateral Sclerosis Research Dementia and Cognitive Impairment Research Genetic Neurodegenerative Diseases Neurogenesis and neuroplasticity mechanisms Nuclear Receptors and Signaling Neuroscience and Neuropharmacology Research Cholinesterase and Neurodegenerative Diseases Neurological Disease Mechanisms and Treatments Mitochondrial Function and Pathology Nerve injury and regeneration Autophagy in Disease and Therapy Cellular transport and secretion Neurogenetic and Muscular Disorders Research Neurological disorders and treatments Tryptophan and brain disorders Neurological diseases and metabolism Lysosomal Storage Disorders Research Prion Diseases and Protein Misfolding RNA Research and Splicing Computational Drug Discovery Methods Endoplasmic Reticulum Stress and Disease S100 Proteins and Annexins

Related Journals

IS
Implementation Science BioMed Central
ID
Infectious Diseases Of Poverty BioMed Central
MA
Molecular Autism BioMed Central
BB
Brain Behavior And Immunity Elsevier BV
HR
Health Research Policy And Systems BioMed Central
TD
Tropical Diseases Travel Medicine And Vaccines BioMed Central